Avalyn Pharma Inc. (AVLN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Avalyn Pharma Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$25.74
−0.35% today
Market cap
$1.1B
Overall quality
53/100
Kronos AI 30-day
+14.1%
8 of 8 simulated paths end higher
Avalyn Pharma Inc. (AVLN) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.1B. It trades at $25.74, down 0.35% today. Its overall quality score is 53 out of 100, ranked against the whole US market. 3 analysts' average target of $56.33 implies +118.8% from today's price. Kronos AI's 30-day forecast is +14.1% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $56.33 |
| Low – high | $52.00 – $60.00 |
| Analysts | 3 |
| Upside to average | +118.8% |
Kronos AI 30-day forecast
| Expected close | $29.48 (+14.1%) |
| Likely range | +8.2% … +31.5% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 50 |
| Solvency | 65 |
| Growth | 44 |
| Overall | 53 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.